奧星生命科技(06118.HK)預期年度溢利增加至逾800萬元
格隆匯2月28日丨奧星生命科技(06118.HK)公佈,與截至2018年12月31日止年度公司擁有人應占溢利約人民幣10萬元相比,公司預期截至2019年12月31日止年度公司擁有人應占溢利將取得不少於約人民幣800萬元。
預期溢利增加主要由於收入及毛利顯着增加所致,主要歸因於較高水平的2018年12月31日的未完工合同及集團於截至2019年12月31日止年度的訂單額大幅增加,而導致於截至2019年12月31日止年度獲確認的收入及溢利增加。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.